Literature DB >> 6792358

Effects of the calcium-mediated enzymatic cross-linking of membrane proteins on cellular deformability.

B D Smith, P L La Celle, G E Siefring, L Lowe-Krentz, L Lorand.   

Abstract

Excess calcium binding affects the shape and dynamics of cellular deformation of human erythrocytes. It may be hypothesized that incorporation of calcium may modify cellular deformability by processes which include specific cross-linking of membrane proteins with resultant changes in cell shape and deformability. Since previous studies indicate that accumulation of calcium ions causes development of gamma-glutamyl-epsilon-lysine bridges in membrane proteins, under control of a membrane transamidating enzyme which specifically requires calcium ions for activation, experiments were devised to examine the relationship between cross-linking and deformability and to determine the effects of specific inhibitor of membrane protein cross-linking on the calcium-dependent modification of erythrocyte to the echinocytic shape. The elastic shear modulus of the membrane was not significantly affected by calcium-induced cross-linking, indicating that induced shape change, not altered elasticity, causes the observed reduction in cellular deformability. These findings support the interpretation that Ca++-induced and transamidase-catalyzed cross-linking of membrane proteins contributes to fixation of altered cellular shape and decreased cellular deformability.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6792358     DOI: 10.1007/BF02007633

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  18 in total

1.  Accumulation of 1,2-diacylglycerol in the plasma membrane may lead to echinocyte transformation of erythrocytes.

Authors:  D Allan; R H Michell
Journal:  Nature       Date:  1975-11-27       Impact factor: 49.962

2.  A23187 and red cells: changes in deformability, K+, Mg-2+, Ca-2+ and ATP.

Authors:  F H Kirkpatrick; D G Hillman; P L La Celle
Journal:  Experientia       Date:  1975-06-15

3.  Role of the intrinsic transglutaminase in the Ca2+-mediated crosslinking of erythrocyte proteins.

Authors:  L Lorand; L B Weissmann; D L Epel; J Bruner-Lorand
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205

4.  MECHANICAL PROPERTIES OF THE RED CELL MEMBRANE. II. VISCOELASTIC BREAKDOWN OF THE MEMBRANE.

Authors:  R P RAND
Journal:  Biophys J       Date:  1964-07       Impact factor: 4.033

5.  MECHANICAL PROPERTIES OF THE RED CELL MEMBRANE. I. MEMBRANE STIFFNESS AND INTRACELLULAR PRESSURE.

Authors:  R P RAND; A C BURTON
Journal:  Biophys J       Date:  1964-03       Impact factor: 4.033

6.  Scanning electron microscopy of erythrocyte deformation: the influence of a calcium ionophore, A23187.

Authors:  J G White
Journal:  Semin Hematol       Date:  1976-04       Impact factor: 3.851

7.  Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.

Authors:  G Fairbanks; T L Steck; D F Wallach
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

8.  Pathophysiologic aspects of sickle cell anemia.

Authors:  C A Finch
Journal:  Am J Med       Date:  1972-07       Impact factor: 4.965

9.  The use of ionophores of rapid loading of human red cells with radioactive cations for cation-pump studies.

Authors:  B Sarkadi; I Szász; G Gárdos
Journal:  J Membr Biol       Date:  1976-05       Impact factor: 1.843

10.  The binding of calcium ions by erythrocytes and 'ghost' -cell membranes.

Authors:  C Long; B Mouat
Journal:  Biochem J       Date:  1971-08       Impact factor: 3.857

View more
  10 in total

1.  Nucleotide binding by the erythrocyte transglutaminase/Gh protein, probed with fluorescent analogs of GTP and GDP.

Authors:  S N Murthy; L Lorand
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

2.  Interactions of recombinant mouse erythrocyte transglutaminase with membrane skeletal proteins.

Authors:  Edgar Gutierrez; L Amy Sung
Journal:  J Membr Biol       Date:  2007-09-01       Impact factor: 1.843

Review 3.  Transglutaminases.

Authors:  L Lorand; S M Conrad
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

4.  Temperature transition of human hemoglobin at body temperature: effects of calcium.

Authors:  C Kelemen; S Chien; G M Artmann
Journal:  Biophys J       Date:  2001-06       Impact factor: 4.033

Review 5.  Transglutaminase-mediated remodeling of the human erythrocyte membrane skeleton: relevance for erythrocyte diseases with shortened cell lifespan.

Authors:  Laszlo Lorand; S N Prasanna Murthy; Anwar A Khan; Weihua Xue; Oksana Lockridge; Athar H Chishti
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  2011

6.  A study of the dynamic properties of the human red blood cell membrane using quasi-elastic light-scattering spectroscopy.

Authors:  R B Tishler; F D Carlson
Journal:  Biophys J       Date:  1993-12       Impact factor: 4.033

7.  Divalent cations increase lipid order in erythrocytes and susceptibility to secretory phospholipase A2.

Authors:  Rebekah S Vest; Laurie J Gonzales; Seth A Permann; Emily Spencer; Lee D Hansen; Allan M Judd; John D Bell
Journal:  Biophys J       Date:  2004-04       Impact factor: 4.033

8.  Association of a transglutaminase-related antigen with intermediate filaments.

Authors:  A V Trejo-Skalli; P T Velasco; S N Murthy; L Lorand; R D Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

9.  Tissue transglutaminase (TG2) facilitates phosphatidylserine exposure and calpain activity in calcium-induced death of erythrocytes.

Authors:  Z Sarang; A Mádi; C Koy; S Varga; M O Glocker; D S Ucker; S Kuchay; A H Chishti; G Melino; L Fésüs; Z Szondy
Journal:  Cell Death Differ       Date:  2007-07-06       Impact factor: 15.828

Review 10.  The Effect of Sepsis on the Erythrocyte.

Authors:  Ryon M Bateman; Michael D Sharpe; Mervyn Singer; Christopher G Ellis
Journal:  Int J Mol Sci       Date:  2017-09-08       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.